IRIDEX Corporation (IRIX) P/E Ratio History
Historical price-to-earnings valuation from 1997 to 2016
Loading P/E history...
IRIX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 9, 2026, IRIDEX Corporation (IRIX) trades at a price-to-earnings ratio of -1.9x, with a stock price of $1.03 and trailing twelve-month earnings per share of $-0.30.
The current P/E is 103% below its 5-year average of 72.5x. Over the past five years, IRIX's P/E has ranged from a low of 8.6x to a high of 401.6x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 21.9x, IRIX trades at a 109% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, IRIX trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IRIX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IRIX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $12B | 29.9 | - | +1% | |
| $17B | 30.5 | - | -25% | |
| $160B | 57.2 | 2.63 | +23% | |
| $109B | 34.0 | 2.29Best | +8% | |
| $46B | 43.7 | 6.17 | -74% | |
| $23B | 29.0Lowest | 2.77 | +47%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
IRIX Historical P/E Data (1997–2016)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2016 Q2 | Sat Jul 02 2016 00:00:00 GM | $15.51 | $0.06 | 269.7x | +364% |
| FY2016 Q1 | Sat Apr 02 2016 00:00:00 GM | $10.04 | $0.03 | 401.6x | +591% |
| FY2015 Q4 | $9.29 | $0.04 | 265.4x | +356% | |
| FY2015 Q3 | Sat Oct 03 2015 00:00:00 GM | $7.37 | $0.85 | 8.6x | -85% |
| FY2015 Q2 | Sat Jul 04 2015 00:00:00 GM | $8.22 | $0.86 | 9.5x | -84% |
| FY2015 Q1 | Sat Apr 04 2015 00:00:00 GM | $10.70 | $0.96 | 11.1x | -81% |
| FY2014 Q4 | Wed Dec 31 2014 00:00:00 GM | $8.60 | $0.99 | 8.7x | -85% |
| FY2014 Q3 | Sat Sep 27 2014 00:00:00 GM | $7.13 | $0.17 | 41.9x | -28% |
| FY2014 Q2 | Sat Jun 28 2014 00:00:00 GM | $8.28 | $0.17 | 48.7x | -16% |
| FY2014 Q1 | Sat Mar 29 2014 00:00:00 GM | $8.58 | $0.18 | 47.7x | -18% |
| FY2013 Q4 | $10.17 | $0.22 | 46.2x | -21% | |
| FY2013 Q3 | Sat Sep 28 2013 00:00:00 GM | $6.08 | $0.20 | 30.4x | -48% |
Average P/E for displayed period: 58.2x
See IRIX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRIX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRIX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIRIX — Frequently Asked Questions
Quick answers to the most common questions about buying IRIX stock.
Is IRIX stock overvalued or undervalued?
IRIX trades at -1.9x P/E, below its 5-year average of 72.5x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does IRIX's valuation compare to peers?
IRIDEX Corporation P/E of -1.9x compares to sector median of 21.9x. The discount suggests lower growth expectations or higher risk.
What is IRIX's PEG ratio?
IRIX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1997-2016.